SCDT-32. THERAPEUTIC USE OF VEGF IN BLOOD-BRAIN BARRIER MODULATION
The poor permeability of the blood-brain barrier (BBB) poses a challenge for several effective chemotherapeutic agents against aggressive CNS tumors, such as glioblastoma. Previous studies demonstrated that physiologic vascular endothelial factor (VEGF) ...
Nov 6, 2017 ... Matthew McCord,1 Amelie Vezina,1 Virginia Rodriguez,1 Cody Peer,2 Oliver Hall ,2 William Figg,2 Mark Gilbert,1 and Sadhana Jackson1 ...